Viewing Study NCT00830167


Ignite Creation Date: 2025-12-25 @ 12:41 AM
Ignite Modification Date: 2025-12-25 @ 10:52 PM
Study NCT ID: NCT00830167
Status: COMPLETED
Last Update Posted: 2021-01-25
First Post: 2009-01-26
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Randomized, Double-Blind, Placebo-Controlled Study Of Pregabalin In Patients With Fibromyalgia
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-03
Start Date Type: None
Primary Completion Date: 2011-05
Primary Completion Date Type: ACTUAL
Completion Date: 2011-05
Completion Date Type: ACTUAL
First Submit Date: 2009-01-26
First Submit QC Date: None
Study First Post Date: 2009-01-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2012-04-30
Results First Submit QC Date: None
Results First Post Date: 2012-06-01
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-01-21
Last Update Post Date: 2021-01-25
Last Update Post Date Type: ACTUAL